Literature DB >> 15374337

Age-related changes in barrier function in mouse brain I. Accelerated age-related increase of brain transfer of serum albumin in accelerated senescence prone SAM-P/8 mice with deficits in learning and memory.

M Ueno1, I Akiguchi, H Yagi, H Naiki, Y Fujibayashi, J Kimura, T Takeda.   

Abstract

The time course of brain accumulation of radiolabelled human serum albumin ((125)I-HSA) injected intravenously and the transfer of (125)I-HSA from blood to brain were evaluated in DDD mice using a double isotope technique. The brain accumulation of (125)I-HSA at 3 and 9 h but not at 24 h postinjection and the brain transfer rates were significantly higher in 22-month-old DDD mice than in 4-month-old ones. The brain transfer rates of (125)I-HSA were measured also in senescence accelerated prone mice (SAM-P/8) with age-related deficits in learning and memory, and in senescence accelerated resistant mice (SAM-R/I) without these deficits. The brain transfer rates were significantly higher in 13-month-old SAM-P/8 and 22-month-old SAM-R/1 than in 3-month-old mice of the same strains, respectively. The mean brain transfer rates in five regions observed in 22-month-old DDD mice, 22-month-old SAM-R/1 and 13-month-old SAM-P/8 increased by 31%, 41% and 51% compared with corresponding values in 3- or 4-month-old mice of the same strains. DDD mice and SAM-R/1 mice with normal characteristics of aging showed similar age-related significant changes in brain transfer rates. Age-related increase in the brain transfer rate was manifested at the youngest age in SAM-P/8 among the three strains examined. These findings show that the transfer of human serum albumin into the mouse brain increases with aging and suggest that the barrier function in the mouse brain against macromolecules changes with aging.

Entities:  

Year:  1993        PMID: 15374337     DOI: 10.1016/0167-4943(93)90035-g

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  8 in total

Review 1.  Astrocytic response to cerebral ischemia is influenced by sex differences and impaired by aging.

Authors:  Nioka C Chisholm; Farida Sohrabji
Journal:  Neurobiol Dis       Date:  2015-04-02       Impact factor: 5.996

2.  Decline in Sirtuin-1 expression and activity plays a critical role in blood-brain barrier permeability in aging.

Authors:  Svetlana M Stamatovic; Gabriela Martinez-Revollar; Anna Hu; Jennifer Choi; Richard F Keep; Anuska V Andjelkovic
Journal:  Neurobiol Dis       Date:  2018-09-06       Impact factor: 5.996

Review 3.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

4.  Moxidectin toxicity in senescence-accelerated prone and resistant mice.

Authors:  Vanessa K Lee; Asheesh K Tiwary; Prachi Sharma-Reddy; Karen A Lieber; Douglas K Taylor; Deborah M Mook
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

5.  Immunocytochemical evaluation of the blood-brain barrier to endogenous albumin in the olfactory bulb and pons of senescence-accelerated mice (SAM).

Authors:  M Ueno; D H Dobrogowska; A W Vorbrodt
Journal:  Histochem Cell Biol       Date:  1996-03       Impact factor: 4.304

Review 6.  Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice.

Authors:  Toshio Takeda
Journal:  Neurochem Res       Date:  2009-02-07       Impact factor: 3.996

Review 7.  Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Authors:  Geetika Nehra; Bjoern Bauer; Anika M S Hartz
Journal:  Pharmacol Ther       Date:  2022-01-30       Impact factor: 13.400

8.  Age-Related Functional and Expressional Changes in Efflux Pathways at the Blood-Brain Barrier.

Authors:  Franciska Erdő; Péter Krajcsi
Journal:  Front Aging Neurosci       Date:  2019-07-30       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.